InsidersTradesSigma
Browse the full record of transactions filed by Swain Judith L, Director. Officer active across 1 companies, notably Lexicon Pharmaceuticals, INC.. Aggregated, 1 disclosures have been published. The latest transaction was disclosed on 30 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Judith L. Swain is a Board Member at Lexicon Pharmaceuticals, Inc. She brings valuable expertise in research and development to the board, contributing to informed decision-making regarding the company's projects.